Seiichi Tomotaki

Seiichi Tomotaki

Auto-generated profile, based on publicly available information

Seiichi Tomotaki

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Cardiology
Verified
Journal Article
Closed access
SMSatoshi Masutani
Satoshi Masutani
TITetsuya Isayama
Tetsuya Isayama
TKTohru Kobayashi
Tohru Kobayashi
KPKyongsun Pak
Kyongsun Pak
MMMasashi Mikami
Masashi Mikami
KTKatsuaki Toyoshima
Katsuaki Toyoshima

13 July 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
TITetsuya Isayama
Tetsuya Isayama
FMFuyu Miyake
Fuyu Miyake
RRRinawati Rohsiswatmo
Rinawati Rohsiswatmo
RDRizalya Dewi
Rizalya Dewi
YOYuri Ozawa
Yuri Ozawa
SKSatoshi Kusuda
Satoshi Kusuda
Introduction Reducing neonatal deaths in premature infants in low- and middle-income countries is key to reducing global neonatal mortality. International neonatal networks, along with patient registries of premature infants, have contributed to improving the quality of neonatal care; however, the involvement of low-to-middle-income countries was limited. This project aims to form an international collaboration among neonatal networks in Asia (AsianNeo), including low-, middle- and high-income countries (or regions). Specifically, it aims to determine outcomes in sick newborn infants, especially very low birth weight (VLBW) infants or very preterm infants, with a view to improving the quality of care for such infants. Methods and analysis Currently, AsianNeo comprises nine neonatal networks from Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Taiwan and Thailand. AsianNeo will undertake the following four studies: (1) institutional questionnaire surveys investigating neonatal intensive care unit resources and the clinical management of sick newborn infants, with a focus on VLBW infants (nine countries/regions); (2) a retrospective cohort study to describe and compare the outcomes of VLBW infants among Asian countries and regions (four countries/regions); (3) a prospective cohort study to develop the AsianNeo registry of VLBW infants (six countries/regions); and (4) implementation and evaluation of educational and quality improvement projects in AsianNeo countries and regions (nine countries/regions). Ethics and dissemination The study protocol was approved by the Research Ethics Board of the National Center for Child Health and Development, Tokyo, Japan (reference number 2020–244, 2022–156). The study findings will be disseminated through educational programmes, quality improvement activities, conference presentations and medical journal publications.

9 July 2019 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
STSeiichi Tomotaki
Seiichi Tomotaki
KTKatsuaki Toyoshima
Katsuaki Toyoshima
TSTomoyuki Shimokaze
Tomoyuki Shimokaze
MKMasahiko Kawai
Masahiko Kawai

6 July 2017 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
STSeiichi Tomotaki
Seiichi Tomotaki
KTKatsuaki Toyoshima
Katsuaki Toyoshima
TSTomoyuki Shimokaze
Tomoyuki Shimokaze
JSJun Shibasaki
Jun Shibasaki
HNHiroyuki Nagafuchi
Hiroyuki Nagafuchi

9 April 2024 in Neonatology
Verified
Journal Article
Closed access
PDF file
STSeiichi Tomotaki
Seiichi Tomotaki
TITetsuya Isayama
Tetsuya Isayama
TKTohru Kobayashi
Tohru Kobayashi
SMSatoshi Masutani
Satoshi Masutani
HKHidenori Kawasaki
Hidenori Kawasaki
TIthe PLASE Study Group Investigators
the PLASE Study Group Investigators
Introduction: A feature of the management of extremely preterm infants in Japan is proactive circulatory management using early routine echocardiography performed by neonatologists. Methods: This study was a post hoc analysis of the Patent ductus arteriosus and Left Atrial Size Evaluation in preterm infants (PLASE) study, which is a prospective cohort study including preterm infants admitted to 34 tertiary neonatal intensive care units in Japan between October 2015 and December 2016. We described the details of the treatment strategy of patent ductus arteriosus (PDA) based on early routine echocardiography. Results: In total, 613 preterm infants were included into the analysis. Twenty percent of infants with prophylactic indomethacin were switched to therapeutic cyclooxygenase inhibitor (COX-I) before the completion of the full prophylactic indomethacin course. Therapeutic COX-I was mostly administered based on echocardiographic findings before PDA became symptomatic or hemodynamically significant. Therapeutic COX-I was frequently discontinued after one or two doses before the full course (three doses) was completed. The proportion of infants requiring additional treatment (additional therapeutic COX-I course or surgical PDA closure) after discontinued COX-I courses (<3 doses) compared to infants after completed 3 doses course was significantly lower (after the first therapeutic COX-I course 46% vs. 68%, p < 0.001) or without a significant difference (after the second or third course). Conclusions: The clinical management of PDA in Japan featured (1) COX-I administration based on echocardiographic findings before symptomatic or hemodynamically significant PDA appeared and (2) frequent discontinuation of therapeutic COX-I before completing the standard three doses course.

1 January 2022 in Pediatrics International
Verified
Journal Article
Closed access
MIMasato Ito
Masato Ito
STSeiichi Tomotaki
Seiichi Tomotaki
TITetsuya Isayama
Tetsuya Isayama
HHHiroko Hara
Hiroko Hara
KHKatsuya Hirata
Katsuya Hirata
HAHirokazu Arai
Hirokazu Arai